Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001554795-18-000061
Filing Date
2018-03-23
Accepted
2018-03-23 16:12:44
Documents
41
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K skin0314form10k.htm 10-K 249241
2 EXHIBIT 31.1 skin0314form10kexh31_1.htm EX-31.1 8182
3 EXHIBIT 31.2 skin0314form10kexh31_2.htm EX-31.2 8215
4 EXHIBIT 32.1 skin0314form10kexh32_1.htm EX-32.1 4319
11 GRAPHIC pinnacleheader.jpg GRAPHIC 33855
12 GRAPHIC pinnaclefoot.jpg GRAPHIC 25777
  Complete submission text file 0001554795-18-000061.txt   1055899

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE skin-20171231.xml EX-101.INS 80513
6 XBRL SCHEMA FILE skin-20171231.xsd EX-101.SCH 12940
7 XBRL CALCULATION FILE skin-20171231_cal.xml EX-101.CAL 23032
8 XBRL DEFINITION FILE skin-20171231_def.xml EX-101.DEF 14613
9 XBRL LABEL FILE skin-20171231_lab.xml EX-101.LAB 90203
10 XBRL PRESENTATION FILE skin-20171231_pre.xml EX-101.PRE 69881
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30991 | Film No.: 18710244
SIC: 6770 Blank Checks